Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-AnalysisFrancesco Del Giudice, Ettore De Berardinis, Pietro Viscuso et al.|Cancers|2023Cited by 28
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non–muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk DynamicsJosé Daniel Subiela, F.J. Burgos Revilla, Wojciech Krajewski et al.|European Urology Oncology|2024Cited by 20
Impact of the extent of lymph node dissection on survival outcomes in clinically lymph <scp>node‐positive</scp> bladder cancerMarkus von Deimling, Marc A. Furrer, Laura S. Mertens et al.|British Journal of Urology|2023Cited by 19
The optimal number of induction chemotherapy cycles in clinically lymph node‐positive bladder cancerMarkus von Deimling, Laura S. Mertens, Marc A. Furrer et al.|British Journal of Urology|2024Cited by 7